5% Minoxidil HAIR GROWTH SPARY

Manufacturer
Guangzhou Yixin Cross-border E-commerce Co., Ltd.
Effective date
2025-10-30
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:41:14

Label at a glance#

Product5%MinoxidilHairgrowthSpray
Active ingredientMINOXIDIL
Label structure11 sections

Indications and uses

to regrow hair on the scalp to help reverse hereditary hair loss

Dosage and administration

For external use only.

Label contents#

Full prescribing information#

Active ingredients

COMPONENTS

Minoxidil 5% Hair regrowth treatment

Uses

INDICATIONS & USAGE SECTION

to regrow hair on the scalp
to help reverse hereditary hair loss

Purpose

OTC - PURPOSE SECTION

to regrow hair on the scalp
to help reverse hereditary hair loss

Warnings

WARNINGS SECTION

For external use only.

Flammable: Keep away from fire or flame

Dosage and administration

DOSAGE & ADMINISTRATION SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

you have no family history of hair loss

your hairloss is sudden and/or patchy

you do not know the reason for your hair loss

you are under 18 years of age.

Do not use on babies and children.

your scalp is red, inflamed,infected, irritated, or painfulyou use other medicines on the scalp

When using section

OTC - WHEN USING SECTION

do not apply on other parts of the body

avoid contact with the eyes. in case of accidental contact, rinse eyes with large amountsof cool tap water.

some people have experienced changes in hair color and/or texture

it takes time to regrow hair. Results may occur at 2 months with twice a day usage. For somemen, you mav need to use this product for at least 4 months before vou see results.

the amount of hair regrowth is diferent for each person. This product will not work for all men.

stop use

OTC - STOP USE SECTION

chest pain, rapid heartbeat, faintness, or dizziness occurs

sudden.unexplained weight gain occurs

your hands or feet swell

scalo irritation or redness occurs

unwanted facial hair growth occurs

you do not see hair regrowth in 4 months

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.lf swallowed, get medical help or contacta Poison Control Center right away.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Biotin, Castor oil, Rosemary Oil, Panthenol,Niacinamide,Ethanol,Glycerin,Deionized Water

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84778-109-015%MinoxidilHairgrowthSpray1 in 1 BOXSHAMPOO13
84778-109-015%MinoxidilHairgrowthSpray60 mL in 1 BOTTLESHAMPOO603

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84778-10984778-109-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12025-09-26full-release2026-06-01 01:14:57

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
425d93d4-e5b1-3635-e063-6394a90a24f13fb36757-bdf5-8aa6-e063-6394a90a7b012025-10-30WarningsExact identifier
spl id: 425d93d4-e5b1-3635-e063-6394a90a24f1
spl set id: 3fb36757-bdf5-8aa6-e063-6394a90a7b01

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.